CRL (CRL) Stock Price & Analysis
CRL (CRL) fell 1.65% to USD 288.5 as of September 8, 2026 at 03:33 UTC, according to Nexqual real-time market data.
CRL last closed at USD 288.5; the session ranged USD 285.34–291.65 on volume of 735,576 shares. Market capitalization is —, with a 52-week range of USD 144.26–303.31 (NYQ). Source: Nexqual, September 8, 2026 at 03:33 UTC.
Key Statistics (as of September 8, 2026 at 03:33 UTC)
| Price | USD 288.5 |
|---|---|
| Change | ▼ 1.65% (down) |
| Previous Close | USD 288.5 |
| Open | USD 288.5 |
| Day Range | USD 285.34 – 291.65 |
| 52-Week Range | USD 144.26 – 303.31 |
| Volume | 735,576 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (CRL)
Nexqual's technical model rates CRL "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 03:33 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 61.91 (neutral) |
| vs SMA50 | Above (USD 254.63) |
| MACD | 11.31 (positive) |
From CRL's Latest SEC 10-K Filing (filed 2026-02-18)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TECH | Bio-Techne Corp | USD 72.43 | ▲ 0.18% |
| IQV | IQVIA Holdings, Inc. | USD 267.77 | ▲ 1.49% |
| COO | The Cooper Companies, Inc. | USD 69.59 | ▼ 0.2% |
| BIO | Bio-Rad Laboratories, Inc. | USD 386.11 | ▼ 0.62% |
| WST | West Pharmaceutical Services, I | USD 339.97 | ▼ 0.78% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 03:33 UTC. This page is informational and not investment advice.